The inverse electron demand Diels-Alder cycloaddition with carbon-11 and fluorine-18: A gateway to pretargeted imaging across the blood-brain barrier
- PMID: 37147795
- DOI: 10.1002/jlcr.4029
The inverse electron demand Diels-Alder cycloaddition with carbon-11 and fluorine-18: A gateway to pretargeted imaging across the blood-brain barrier
Abstract
There is increased focus on developing tools to image large biomolecules, such as antibodies, within the brain using positron emission tomography (PET). The inverse electron demand Diels-Alder cycloaddition (IEDDA) reaction has offered the greatest prospect of achieving such a feat and has gained much interest over the past decade. The fast reaction kinetics of the IEDDA reaction opens up the possibility of utilising a pretargeted approach, whereby the subject is pretreated with a biomolecule that has high specificity for its target. A radiolabelled second component is then administered to the subject, enabling the biomolecule to be visualised by PET. However, for this to become common practice, there is a need for the development of either radiolabelled trans-cyclooctenes (TCOs) or tetrazines that can cross the blood-brain barrier (BBB). This review highlights the advancements in the development of both radiolabelled TCOs and tetrazines, which have been radiolabelled with either carbon-11 or fluorine-18 and show promise or have been evaluated for use in pretargeted PET imaging across the BBB.
Keywords: blood-brain barrier; carbon-11; inverse electron demand Diels-Alder reaction; pretargeted imaging; tetrazine; trans-cyclooctene.
© 2023 The Authors. Journal of Labelled Compounds and Radiopharmaceuticals published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Ametamey SM, Honer M, Schubiger PA. Molecular imaging with PET. Chem Rev. 2008;108(5):1501-1516. doi:10.1021/cr0782426
-
- Stéen EJL, Edem PE, Nørregaard K, et al. Pretargeting in nuclear imaging and radionuclide therapy: improving efficacy of theranostics and nanomedicines. Biomaterials. 2018;179:209-245. doi:10.1016/j.biomaterials.2018.06.021
-
- van den Broek SL, Shalgunov V, Herth MM. Transport of nanomedicines across the blood-brain barrier: challenges and opportunities for imaging and therapy. Biomater Adv. 2022;141:213125. doi:10.1016/j.bioadv.2022.213125
-
- Nance E, Pun SH, Saigal R, Sellers DL. Drug delivery to the central nervous system. Nat Rev Mater. 2021;7(4):314-331. doi:10.1038/s41578-021-00394-w
-
- Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959-1972. doi:10.1038/jcbfm.2012.126
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous